Revenue
2018
2019
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $36,251 | — | — | — | — | — | $0 | $0 | — | — | — |
| Gross profit | −$657,432 | — | — | — | — | — | — | — | — | — | — |
| Research & development | $925,482 | $903,941 | $5.0M | $8.8M | $17.0M | $5.9M | $8.7M | $5.8M | $2.4M | $2.5M | $1.4M |
| Operating expenses | $6.4M | $15.6M | $15.8M | $12.7M | $59.1M | $26.4M | $14.7M | $13.4M | — | — | — |
| Operating income | −$7.1M | −$15.6M | −$15.8M | −$12.7M | −$59.1M | −$26.4M | −$14.7M | −$13.4M | −$10.2M | −$6.3M | −$4.7M |
| EBITDAderived | −$6.5M | −$15.6M | −$15.7M | −$12.6M | −$59.0M | −$26.4M | −$14.7M | −$12.6M | −$9.5M | −$5.6M | −$4.0M |
| Net income | −$6.4M | −$18.1M | −$15.8M | −$14.6M | −$58.5M | −$32.7M | −$15.2M | −$13.5M | −$11.1M | −$14.6M | −$5.9M |
| Basic EPSper diluted share | -$4.16 | -$15.99 | -$47.88 | -$416.94 | -$1,988.53 | -$14.68 | $22,425,564.00 | $15,439,310.00 | -$1.04 | -$2.24 | -$1.63 |
| Diluted EPSper diluted share | -$4.16 | -$15.99 | -$47.88 | -$416.94 | -$1,988.53 | -$14.68 | $22,425,564.00 | $15,439,310.00 | -$1.04 | -$2.24 | -$1.63 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jan 6, 2025Form 4 | Romano SarahChief Financial Officer | SellCommon Stock | 727 | $0.64 | $465.28 | 17.3K |
| Oct 9, 2024Form 4 | Romano SarahChief Financial Officer | SellCommon Stock | 476 | $0.45 | $214.20 | 18.0K |
| Jul 2, 2024Form 4 | Romano SarahChief Financial Officer | SellCommon Stock | 621 | $1.07 | $664.47 | 18.5K |
| Jul 2, 2024Form 4 | SAPIRSTEIN JAMESChairman and CEO | SellCommon Stock | 1.3K | $1.07 | $1.4K | 35.8K |